mayo clinic glp 1 GLP-1RA and thyroid cancer: New study suggests detection bias, not causation Weight loss treatment is not
Description
Regulatory pressure, lower prices, and new retail agreements are shifting the balance in the US GLP-1 market.
In addition to diabetes treatment, the function of metf...
Adults with pulmonary arterial hypertension using vs
Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020
